Dear Inquirant,
Thank you for your interest in the Michigan tinnitus device. We appreciate your eagerness to find relief from tinnitus.
We are excited to share our progress with you. Our recently published second human trial, featured in the
JAMA Open Network and a
University of Michigan press release, has shown very encouraging results. We are actively working to obtain FDA clearance through Auricle, Inc., a privately held company.
While we cannot provide specific timelines for regulatory clearance or commercial availability at this time, please be assured that we are fully committed to achieving these goals.
We understand the impact tinnitus can have on your quality of life, and we are optimistic about the positive outcomes our device can offer. We greatly appreciate your patience and support during this process. Importantly, despite my retirement from the University of Michigan, I remain an active emerita professor and will continue in my role as Chief Scientific Officer of Auricle, Inc.
Thank you for your understanding and unwavering interest in our work.
Warm regards,
Susan E. Shore, PhD
Professor Emerita, University of Michigan
Chief Scientific Officer, Auricle, Inc.